Jia Yueting's Faraday Future, in partnership with the Sign Foundation, has invested $41 million through a PIPE transaction in QLGN to kickstart its cryptocurrency business.

BlockBeats News, September 20, Faraday Future (NASDAQ: FFAI) announced today that it will strategically invest $41 million through a PIPE transaction in Qualigen Therapeutics (NASDAQ: QLGN), which will be renamed CXC10 and transition to a crypto and Web3 business platform.

The investment lineup is strong, including not only Faraday Future and individual investor Jia Yueting, but also Sign, a blockchain technology company that builds on-chain public infrastructure for governments and enterprises worldwide, providing secure solutions from digital identity verification to token distribution.